NEW DELHI, April 21 (Reuters) - The Serum Institute of India
will be able to raise its monthly output of the AstraZeneca
COVID-19 vaccine to 100 million doses by July from 60-70 million
now, later than a previous timeline of end-May, its chief
executive Adar Poonawalla told CNBC-TV18.
(Reporting by Chandini Monappa and Krishna N. Das; Editing by
Andrew Heavens)
TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth
(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.
Read more